ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $605,136,441 | +20.8% | 4,954,855 | +2.1% | 3.63% | +10.7% |
| Q3 2022 | $501,085,000 | +11.1% | 4,852,655 | 0.0% | 3.28% | +28.3% |
| Q2 2022 | $451,103,000 | -15.4% | 4,852,655 | +6.8% | 2.56% | -16.5% |
| Q1 2022 | $533,003,000 | -12.8% | 4,541,604 | 0.0% | 3.06% | +3.0% |
| Q4 2021 | $610,982,000 | -15.6% | 4,541,604 | 0.0% | 2.97% | -6.5% |
| Q3 2021 | $723,886,000 | +55.4% | 4,541,604 | +28.3% | 3.18% | +55.5% |
| Q2 2021 | $465,723,000 | +2.1% | 3,540,270 | 0.0% | 2.04% | +3.4% |
| Q1 2021 | $456,270,000 | -22.7% | 3,540,270 | 0.0% | 1.98% | -11.1% |
| Q4 2020 | $590,446,000 | +8.1% | 3,540,270 | 0.0% | 2.22% | +1.9% |
| Q3 2020 | $546,334,000 | +9.0% | 3,540,270 | +4.4% | 2.18% | -1.3% |
| Q2 2020 | $501,421,000 | +31.3% | 3,390,270 | 0.0% | 2.21% | -5.9% |
| Q1 2020 | $381,778,000 | -19.1% | 3,390,270 | 0.0% | 2.35% | -6.2% |
| Q4 2019 | $471,654,000 | +44.4% | 3,390,270 | 0.0% | 2.51% | +12.9% |
| Q3 2019 | $326,551,000 | -16.4% | 3,390,270 | 0.0% | 2.22% | -16.3% |
| Q2 2019 | $390,390,000 | -2.2% | 3,390,270 | 0.0% | 2.65% | +3.9% |
| Q1 2019 | $399,035,000 | +124.5% | 3,390,270 | +19.5% | 2.55% | +75.4% |
| Q4 2018 | $177,760,000 | -11.6% | 2,837,352 | 0.0% | 1.46% | +10.0% |
| Q3 2018 | $201,055,000 | +6.5% | 2,837,352 | 0.0% | 1.32% | -6.6% |
| Q2 2018 | $188,741,000 | +1.7% | 2,837,352 | 0.0% | 1.42% | -9.9% |
| Q1 2018 | $185,563,000 | +76.9% | 2,837,352 | +8.3% | 1.57% | +73.0% |
| Q4 2017 | $104,910,000 | +23.2% | 2,618,818 | +11.5% | 0.91% | +31.5% |
| Q3 2017 | $85,145,000 | +75.1% | 2,348,840 | +34.1% | 0.69% | +62.6% |
| Q2 2017 | $48,621,000 | +28.5% | 1,751,463 | +29.6% | 0.42% | +37.1% |
| Q1 2017 | $37,841,000 | +82.7% | 1,351,463 | +32.1% | 0.31% | +52.7% |
| Q4 2016 | $20,711,000 | +38.2% | 1,023,266 | +37.3% | 0.20% | +49.3% |
| Q3 2016 | $14,985,000 | +51.5% | 745,521 | 0.0% | 0.14% | +30.8% |
| Q2 2016 | $9,893,000 | +5.5% | 745,521 | +47.5% | 0.10% | +5.1% |
| Q1 2016 | $9,377,000 | +1.3% | 505,521 | 0.0% | 0.10% | +28.6% |
| Q4 2015 | $9,261,000 | +20.1% | 505,521 | +16.1% | 0.08% | +8.5% |
| Q3 2015 | $7,709,000 | +336.0% | 435,540 | +335.5% | 0.07% | +343.8% |
| Q2 2015 | $1,768,000 | +1.9% | 100,000 | 0.0% | 0.02% | +14.3% |
| Q1 2015 | $1,735,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 10,719,555 | $1,003,779,130 | 19.76% |
| Q Global Advisors, LLC | 285,000 | $26,687 | 17.16% |
| Finepoint Capital LP | 163,772 | $15,335,610 | 7.64% |
| Avoro Capital Advisors LLC | 3,670,000 | $343,658,800 | 5.36% |
| Spyglass Capital Management LLC | 614,618 | $57,552,830 | 4.51% |
| Sofinnova Investments, Inc. | 754,032 | $70,607,556 | 4.45% |
| Saturn V Capital Management LP | 112,473 | $10,531,972 | 4.41% |
| DAFNA Capital Management LLC | 136,212 | $12,754,892 | 3.97% |
| ARS Investment Partners, LLC | 285,918 | $26,773,362 | 3.32% |
| Ghost Tree Capital, LLC | 85,000 | $7,959,400 | 2.62% |